Skip to content

Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06716099
Enrollment
100
Registered
2024-12-04
Start date
2024-12-15
Completion date
2025-12-31
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community Acquired Pneumonia (CAP)

Keywords

CAP, Pneumonia, clinical characteristics

Brief summary

the goal of this observational study is to evaluate the clinical characteristic and outcomes of patients with community-acquired pneumonia admitted to Sohag University Hospital. the researcher will take medical history and clinical examination and investigations of participants . the participants will visit the clinic after one month to be reevaluated again .

Detailed description

Community acquired pneumonia is acute infection of the pulmonary parenchyma that occurs in the community in a patient who has not been hospitalized within 14 days prior to onset of symptoms or hospitalized less than 2 days prior to the onset of symptoms the aim of the study typically focuses on examining the various factors that influence the presentation, management, and outcomes of individuals diagnosed with pneumonia that is acquired outside of a hospital or healthcare setting. Type of the study: observational study Outcomes of interest include: I. Mortality (in hospital and 30 days). II. The need for further mechanical ventilation or ICU admission. III. Duration of hospital stay.

Interventions

None listed

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* The study will include patients ≥18 years old with community acquired pneumonia

Exclusion criteria

1. Patients already was diagnosed as active malignancy before admission 2. Patient on chemotherapy 3. HIV patients 4. Indication of mechanical ventilation on admission

Design outcomes

Primary

MeasureTime frameDescription
improvedwithin one monthwhen the patient is improved and discharged
patients developed complicationswithin one monthwhen patients developed complications like acute kidney injury , septic shock or Disseminated intravascular coagulopathy
Death of patientwithin one month

Secondary

MeasureTime frame
intensive care unit admissionwithin one month

Contacts

Primary ContactRania Abdo Saeed Rania Abdo saeed, MBBCh
rania_abdo_post@med.sohag.edu.eg+2001093776651

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026